PERL: A multicenter clinical trial of allopurinol to pre

Project: Research project

Project Details

Description

PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
StatusFinished
Effective start/end date9/30/136/30/20

Funding

  • JOSLIN DIABETES CENTER, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.